Antinuclear Antibody Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2020–2026

Published Date: 19-Aug-2020 Category: Healthcare Report Format : PDF Report Code: ZMR-1085 Status : Published

Global Demand for Antinuclear Antibody Test market was valued at approximately USD 951.2 million in 2019, and is expected to generate revenue of around USD 2038.2 million by end of 2026, growing at a CAGR of around 11.5 % between 2020 and 2026.

Description

According to the report, global demand for Antinuclear Antibody Test market was valued at approximately USD 951.2 million in 2019, and is expected to generate revenue of around USD 2038.2 million by end of 2026, growing at a CAGR of around 11.5 % between 2020 and 2026.

Global Antinuclear Antibody Test Market: Overview

The antinuclear antibodies are autoantibodies that attach to the specific contents of the nucleus present in the cell. They are also known as antinuclear factor or ANF. The autoantibodies are produced in the human body against the foreign particles but in some cases, the antibodies are produced against human antigen itself. Thus, antinuclear antibody test helps detect the autoantibodies present in the human blood serum. The most commonly used ANA tests include indirect immunofluorescence and enzyme-linked immunosorbent assay test. After the detection of these antinuclear antibodies, its various subtypes can also be determined.

Global Antinuclear Antibody Test Market: Growth Factors

The major factors responsible for the growth of the global antinuclear antibody test market are growing number of autoimmune diseases and also the escalating number of reagent rental agreements. The growing population results in the rise of various diseases in a number of regions which in turn increases the demand for antinuclear antibody test products and fuels the global market growth. The antinuclear antibody test’s accuracy and immediate results render its vast use in the medical field and thus help drive the growth of the global market. But, the cost of these tests makes it a little unaffordable for the customers, which in turn hamper its sale in the global market.

Global Antinuclear Antibody Test Market

Global Antinuclear Antibody Test Market: Segmentation

The global antinuclear antibody test market is bifurcated on the basis of disease, product, end user, technique, and region. The disease segment is further categorized into rheumatoid arthritis, systemic lupus erythematosus, scleroderma, Sjögren’s Syndrome, and other diseases. The product segment is divided into systems, software and services, and reagents & assay kits. The end user segment is bifurcated into physician office laboratories, hospitals, clinical laboratories, and other end users. The technique segment is classified into the multiplex assay, ELISA, and immunofluorescence assay. The assay kits and reagents and hospitals segment are expected to dominate the global market and also helps in increasing the global market growth rate.

Global Antinuclear Antibody Test Market: Regional Analysis

North America is expected to lead the global antinuclear antibody test market followed by Europe, Asia, and the Rest of the World. The major reason for the North American market growth is primarily due to the high incidence of autoimmune diseases, healthcare spending, growing population, and rising number of individuals having medical insurance in the U.S.

Global Antinuclear Antibody Test Market: Competitive Players

The key players in the antinuclear antibody test market include ERBA Diagnostics, Inc., Alere Inc., Trinity Biotech plc, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Antibodies, Inc. The other players in the global market include Immuno Concepts, EUROIMMUN AG, Zeus Scientific, Inc, and Inova Diagnostics. These major companies adopt a number of strategies such as agreements, contracts, new test launch, joint ventures, mergers, and acquisitions in order to obtain a standard position in the market.

Global Antinuclear Antibody Test Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Antinuclear Antibody Test Market, 2016 - 2026, (USD Million)
    • 2.2. Antinuclear Antibody Test Market: Snapshot
  • Chapter 3. Global Antinuclear Antibody Test Market – Industry Analysis
    • 3.1. Antinuclear Antibody Test Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing number of autoimmune diseases
      • 3.2.2. Escalating number of reagent rental agreements
    • 3.3. Restraints
      • 3.3.1. High Cost
    • 3.4. Opportunity
      • 3.4.1. Emerging Markets
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Disease segment
      • 3.6.2. Market attractiveness analysis by Product segment
      • 3.6.3. Market attractiveness analysis by End user segment
      • 3.6.4. Market attractiveness analysis by Technique segment
      • 3.6.5. Market attractiveness analysis by regional segment
  • Chapter 4. Global Antinuclear Antibody Test Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Antinuclear Antibody Test market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Antinuclear Antibody Test Market – Disease Segment Analysis
    • 5.1. Global Antinuclear Antibody Test market overview: by Disease
      • 5.1.1. Global Antinuclear Antibody Test market revenue share, by Disease, 2019 and 2026
    • 5.2. Rheumatoid arthritis
      • 5.2.1. Global Antinuclear Antibody Test market by Rheumatoid arthritis, 2016-2026 (USD Million)
    • 5.3. Systemic lupus erythematosus
      • 5.3.1. Global Antinuclear Antibody Test market by Systemic lupus erythematosus, 2016-2026 (USD Million)
    • 5.4. Scleroderma
      • 5.4.1. Global Antinuclear Antibody Test market by Scleroderma, 2016-2026 (USD Million)
    • 5.5. Sjögren’s syndrome
      • 5.5.1. Global Antinuclear Antibody Test market by Sjögren’s syndrome, 2016-2026 (USD Million)
    • 5.6. Other diseases
      • 5.6.1. Global Antinuclear Antibody Test market by Other diseases, 2016-2026 (USD Million)
  • Chapter 6. Global Antinuclear Antibody Test Market – Product Segment Analysis
    • 6.1. Global Antinuclear Antibody Test market overview: by Product
      • 6.1.1. Global Antinuclear Antibody Test market revenue share, by Product, 2019 and 2026
    • 6.2. Systems
      • 6.2.1. Global Antinuclear Antibody Test market by Systems, 2016-2026 (USD Million)
    • 6.3. Software and services
      • 6.3.1. Global Antinuclear Antibody Test market by Software and services, 2016-2026 (USD Million)
    • 6.4. Reagents & assay kits
      • 6.4.1. Global Antinuclear Antibody Test market by Reagents & assay kits, 2016-2026 (USD Million)
  • Chapter 7. Global Antinuclear Antibody Test Market – End user Segment Analysis
    • 7.1. Global Antinuclear Antibody Test market overview: by End user
      • 7.1.1. Global Antinuclear Antibody Test market revenue share, by End user, 2019 and 2026
    • 7.2. Physician office laboratories
      • 7.2.1. Global Antinuclear Antibody Test market by Physician office laboratories, 2016-2026 (USD Million)
    • 7.3. Hospitals
      • 7.3.1. Global Antinuclear Antibody Test market by Hospitals, 2016-2026 (USD Million)
    • 7.4. Clinical laboratories
      • 7.4.1. Global Antinuclear Antibody Test market by Clinical laboratories, 2016-2026 (USD Million)
    • 7.5. Other end users
      • 7.5.1. Global Antinuclear Antibody Test market by Other end users, 2016-2026 (USD Million)
  • Chapter 8. Global Antinuclear Antibody Test Market – Technique Segment Analysis
    • 8.1. Global Antinuclear Antibody Test market overview: by technique
      • 8.1.1. Global Antinuclear Antibody Test market revenue share, by technique, 2019 and 2026
    • 8.2. Multiplex assay
      • 8.2.1. Global Antinuclear Antibody Test market by Multiplex assay, 2016-2026 (USD Million)
    • 8.3. ELISA
      • 8.3.1. Global Antinuclear Antibody Test market by ELISA, 2016-2026 (USD Million)
    • 8.4. Immunofluorescence Assay
      • 8.4.1. Global Antinuclear Antibody Test market by Immunofluorescence Assay, 2016-2026 (USD Million)
  • Chapter 9. Global Antinuclear Antibody Test Market - Regional Analysis
    • 9.1. Global Antinuclear Antibody Test market overview: by region
      • 9.1.1. Global Antinuclear Antibody Test market revenue share, by region, 2019 and 2026
    • 9.2. North America
      • 9.2.1. North America Antinuclear Antibody Test market, by country, 2016-2026 (USD Million)
      • 9.2.2. North America Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
      • 9.2.3. North America Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
      • 9.2.4. North America Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
      • 9.2.5. North America Antinuclear Antibody Test market revenue, by technique, 2016-2026 (USD Million)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.2.6.2. The U.S. Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.2.6.3. The U.S. Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.2.6.4. The U.S. Antinuclear Antibody Test market revenue, by technique, 2016-2026 (USD Million)
      • 9.2.7. Rest of North America
        • 9.2.7.1. Rest of North America Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.2.7.2. Rest of North America Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.2.7.3. Rest of North America Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.2.7.4. Rest of North America Antinuclear Antibody Test market revenue, by technique, 2016-2026 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe Antinuclear Antibody Test market, by country, 2016-2026 (USD Million)
      • 9.3.2. Europe Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
      • 9.3.3. Europe Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
      • 9.3.4. Europe Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
      • 9.3.5. Europe Antinuclear Antibody Test market revenue, by technique, 2016-2026 (USD Million)
      • 9.3.6. U.K.
        • 9.3.6.1. U.K. Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.3.6.2. U.K. Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.3.6.3. U.K. Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.3.6.4. U.K. Antinuclear Antibody Test market revenue, by technique, 2016-2026 (USD Million)
      • 9.3.7. France
        • 9.3.7.1. France Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.3.7.2. France Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.3.7.3. France Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.3.7.4. France Antinuclear Antibody Test market revenue, by technique, 2016-2026 (USD Million)
      • 9.3.8. Germany
        • 9.3.8.1. Germany Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.3.8.2. Germany Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.3.8.3. Germany Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.3.8.4. Germany Antinuclear Antibody Test market revenue, by technique, 2016-2026 (USD Million)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.3.9.2. Rest of Europe Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.3.9.3. Rest of Europe Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.3.9.4. Rest of Europe Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Antinuclear Antibody Test market, by country, 2016-2026 (USD Million)
      • 9.4.2. Asia Pacific Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
      • 9.4.3. Asia Pacific Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
      • 9.4.4. Asia Pacific Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
      • 9.4.5. Asia Pacific Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
      • 9.4.6. China
        • 9.4.6.1. China Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.4.6.2. China Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.4.6.3. China Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.4.6.4. China Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
      • 9.4.7. Japan
        • 9.4.7.1. Japan Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.4.7.2. Japan Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.4.7.3. Japan Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.4.7.4. Japan Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
      • 9.4.8. India
        • 9.4.8.1. India Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.4.8.2. India Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.4.8.3. India Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.4.8.4. India Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.4.9.2. Rest of Asia Pacific Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.4.9.3. Rest of Asia Pacific Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.4.9.4. Rest of Asia Pacific Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America Antinuclear Antibody Test market, by country, 2016-2026 (USD Million)
      • 9.5.2. Latin America Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
      • 9.5.3. Latin America Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
      • 9.5.4. Latin America Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
      • 9.5.5. Latin America Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.5.6.2. Brazil Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.5.6.3. Brazil Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.5.6.4. Brazil Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
        • 9.5.7.2. Rest of Latin America Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
        • 9.5.7.3. Rest of Latin America Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
        • 9.5.7.4. Rest of Latin America Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
    • 9.6. Middle East & Africa
      • 9.6.1. Middle East & Africa Antinuclear Antibody Test market, 2016-2026 (USD Million)
      • 9.6.2. Middle East & Africa Antinuclear Antibody Test market revenue, by Disease, 2016-2026 (USD Million)
      • 9.6.3. Middle East & Africa Antinuclear Antibody Test market revenue, by Product, 2016-2026 (USD Million)
      • 9.6.4. Middle East & Africa Antinuclear Antibody Test market revenue, by End user, 2016-2026 (USD Million)
      • 9.6.5. Middle East & Africa Antinuclear Antibody Test market revenue, by Technique, 2016-2026 (USD Million)
  • Chapter 10. Company Profiles
    • 10.1. ERBA Diagnostics.
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. Alere Inc
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Trinity Biotech plc
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. Bio-Rad Laboratories, Inc.
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Thermo Fisher Scientific, Inc
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Antibodies, Inc
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Immuno Concepts
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. EUROIMMUN AG,
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. Zeus Scientific, Inc.
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. Inova Diagnostics
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments

Methodology

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com